Style | Citing Format |
---|---|
MLA | Kheirollahi A, et al.. "Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women." Lipids in Health and Disease, vol. 19, no. 1, 2020, pp. -. |
APA | Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, Sadeghi A (2020). Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women. Lipids in Health and Disease, 19(1), -. |
Chicago | Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, Sadeghi A. "Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women." Lipids in Health and Disease 19, no. 1 (2020): -. |
Harvard | Kheirollahi A et al. (2020) 'Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women', Lipids in Health and Disease, 19(1), pp. -. |
Vancouver | Kheirollahi A, Teimouri M, Karimi M, Vatannejad A, Moradi N, Borumandnia N, et al.. Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women. Lipids in Health and Disease. 2020;19(1):-. |
BibTex | @article{ author = {Kheirollahi A and Teimouri M and Karimi M and Vatannejad A and Moradi N and Borumandnia N and Sadeghi A}, title = {Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women}, journal = {Lipids in Health and Disease}, volume = {19}, number = {1}, pages = {-}, year = {2020} } |
RIS | TY - JOUR AU - Kheirollahi A AU - Teimouri M AU - Karimi M AU - Vatannejad A AU - Moradi N AU - Borumandnia N AU - Sadeghi A TI - Evaluation of Lipid Ratios and Triglyceride-Glucose Index As Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women JO - Lipids in Health and Disease VL - 19 IS - 1 SP - EP - PY - 2020 ER - |